Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 -2.26%66 Gross Margin % is 23.19% as of Mar. 2026, which is 3% below its 10-year median of 24.01. GuruFocus rates BOM:543963 with a GF Score™ of 66/100 and a GF Value™ of ₹57.02 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 942 Drug Manufacturers companies, Shelter Pharma ranks worse than 87.47% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shelter Pharma had a gross margin of 23.19% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shelter Pharma Gross Margin % Related Terms
Shelter Pharma Gross Margin % Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shelter Pharma (BOM:543963) has a Gross Margin % of 23.19% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shelter Pharma and its competitors. This is near median its historical median of 24.01. Over the past decade, Shelter Pharma's Gross Margin % has ranged from 5.88 to 26.91. According to the industry distribution chart, Shelter Pharma ranks #824 out of 942 companies in the Drug Manufacturers industry, placing it in the top 87.5%.
Is Shelter Pharma's Gross Margin % too high?
Shelter Pharma's current Gross Margin % of 23.19% is near median its 10-year median of 24.01. Over the past 10 years, this metric has ranged from a low of 5.88 to a high of 26.91. The Drug Manufacturers industry median Gross Margin % is 48.50. Shelter Pharma's value of 23.19% is 52.2% below this industry median. Based on the distribution chart, Shelter Pharma ranks #824 out of 942 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #824 out of 942 companies for Gross Margin %. This places Shelter Pharma in the lower half of its industry. The industry median Gross Margin % is 48.50. Shelter Pharma's value of 23.19% is 52.2% below this benchmark. Historically, Shelter Pharma's own Gross Margin % has ranged from 5.88 to 26.91 over the past decade. While the company's 10-year median is 24.01 vs. the industry median of 48.50, Shelter Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.50, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current Gross Margin % of 23.19% is 52.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current Gross Margin % is 23.19%, which is near median its own 10-year median of 24.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.02, compared to a current price of ₹26.00 — trading 54.4% below its estimated fair value. The current Gross Margin % is 23.19%, which is near median its 10-year median of 24.01 and 52.2% below the Drug Manufacturers industry median of 48.50. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current Gross Margin % is 23.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹26.00 is trading 54.4% below its estimated GF Value™ of ₹57.02.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
Gross Margin %: 23.19% (near median its 10-year median of 24.01)
GF Value™: ₹57.02 vs. price of ₹26.00 (54.4% below fair value)
Industry Position: 52.2% below the Drug Manufacturers median (#824 of 942)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score
Get the complete analysis for BOM:543963
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
